Technology
Software Service
Medical

Medidata Solutions

$75.84
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$4.18 (-5.22%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell MDSO and other stocks, options, ETFs, and crypto commission-free!

About

Medidata Solutions, Inc. provides cloud based solutions for life sciences for customer's clinical development processes including concept, conclusion, research optimization, and development investments. Its cloud-based technology including its unified platform, pioneering analytics, and clinical technology allows the development of new therapies pharmaceutical companies, biotech, and medical device firms, academic medical centers and contract research organizations around the world. Read More It operates through the following geographical segments: United States, Japan, and Other. The company was founded by Glen M. de Vries, Edward F. Ikeguchi and Tarek A. Sherif in June 1999 and is headquartered in New York, NY.

Employees
1,998
Headquarters
New York, New York
Founded
1999
Market Cap
4.65B
Price-Earnings Ratio
89.18
Dividend Yield
0.00
Average Volume
593.56K
High Today
$79.44
Low Today
$75.81
Open Price
$79.17
Volume
144.06K
52 Week High
$88.87
52 Week Low
$60.10

Collections

Technology
Software Service
Medical
Pharmaceutical
Health
US
North America

News

Yahoo FinanceMar 14

Why Is Medidata (MDSO) Up 3.4% Since Last Earnings Report?

It has been about a month since the last earnings report for Medidata Solutions (MDSO). Shares have added about 3.4% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Medidata due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers. Medidata Q4 Earnings Beat on Strong Subsc...

24
TradingNewsNowMar 13

Buy or Sell: Medidata Solutions (NASDAQ: MDSO)

Medidata Solutions is in the application software industry and technology sector. The company CEO is Tarek A Sherif. Medidata Solutions Inc provides cloud-based solutions for life sciences. Its customers are pharmaceutical, biotechnology, and medical device companies, academic institutions, and contract research organizations. Previous Intraday Trading Performance: The MDSO stock showed a previous change of 0.71% with an open at 74.75 and a close of 75.04. It reached an intraday high of 75.71 and a low of...

15
Simply Wall StMar 7

Will Medidata Solutions, Inc.’s (NASDAQ:MDSO) Earnings Grow In The Year Ahead?

On 31 December 2018, Medidata Solutions, Inc. (NASDAQ:MDSO) announced its latest earnings update. Overall, analyst forecasts appear to be pessimistic, as a -16% fall in profits is expected in the upcoming year relative to the past 5-year average growth rate of 42%. Presently, with latest-twelve-month earnings at US$52m, we should see this fall to US$43m by 2020. Below is a brief commentary around Medidata Solutions’s earnings outlook going forward, which may give you a sense of market sentiment for the comp...

17

Earnings

$0.28
$0.34
$0.39
$0.45
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Apr 18, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.